Evidence map›Paper›PMID 31914120›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway.

Chongwen Ma, Bin Geng, Xiaohui Zhang, Rui Li, Xinxin Yang, Yayi Xia

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chongwen MaDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Bin GengDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Xiaohui ZhangDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Rui LiDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Xinxin YangDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Yayi XiaDepartment of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China (mainland).
Lanzhou University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Although extracellular signal-regulated kinase 5 (ERK5) is known to be critical for osteoclast differentiation, there are few studies on how fluid shear stress (FSS) regulates osteoclast differentiation through the ERK5 signaling pathway. We examined the expression of nuclear factor of activated T cells c1 (NFATc1) in RAW264.7 cells and its downstream factors, including cathepsin K (CTSK), tartrate-resistant acid phosphatase (TRAP), matrix metalloproteinases-9 (MMP-9) and their relationship with ERK5. MATERIAL AND METHODS RAW264.7 cells were treated with RANKL, XMD8-92 (ERK5 inhibitor), and then loaded onto 12 dyn/cm² FSS for 4 days. Endpoints measured were osteoclast differentiation, bone resorption, and TRAP activity. Cell viability was detected by using the Cell Counting Kit-8 (CCK-8) assay. Western blot was used to analyze protein expression of phosphorylated-ERK5 (p-ERK5), NFATc1, CTSK, TRAP, and MMP-9. RESULTS FSS inhibited osteoclast differentiation and expression of NFATc1, CTSK, TRAP, and MMP-9; cell viability was not affected. ERK5 expression increased by FSS but not by RANKL, and it was blocked by XMD8-92. Furthermore, FSS suppressed osteoclast differentiation in RAW264.7 cells through ERK5 pathway. CONCLUSIONS Our findings demonstrated that FSS inhibited osteoclast differentiation in RAW264.7 cells via the ERK5 pathway through reduced NFATc1 expression and its downstream factors MMP-9, CTSK, and TRAP.

Indexed as

AnimalsBiomechanical PhenomenaBone ResorptionCathepsin KCell DifferentiationCell LineCell SurvivalHematopoiesisMatrix Metalloproteinase 9MiceMitogen-Activated Protein Kinase 7NFATC Transcription FactorsOsteoclastsPhosphorylationRAW 264.7 CellsStress, MechanicalAcp5 protein, mouseCathepsin KCtsk protein, mouseMatrix Metalloproteinase 9Mitogen-Activated Protein Kinase 7Mmp9 protein, mouseNFATC Transcription FactorsTartrate-Resistant Acid Phosphatase

Identifiers

PMID31914120
PMCPMC6977602
OpenAlexW2999211833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.